9-136712727-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_152421.4(DIPK1B):āc.62A>Cā(p.Gln21Pro) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000148 in 1,349,522 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152421.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151450Hom.: 0 Cov.: 32
GnomAD4 exome AF: 8.35e-7 AC: 1AN: 1198072Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 586680
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151450Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73984
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2024 | The c.62A>C (p.Q21P) alteration is located in exon 1 (coding exon 1) of the FAM69B gene. This alteration results from a A to C substitution at nucleotide position 62, causing the glutamine (Q) at amino acid position 21 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at